Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Histone deacetylase 6 (Homo sapiens (Human)) | BDBM249365 (US9464073, 002 | US9884850, Compound 2) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.40 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Acetylon Pharmaceuticals, Inc. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... | US Patent US9464073 (2016) BindingDB Entry DOI: 10.7270/Q2TD9W8Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 6 (Homo sapiens (Human)) | BDBM249364 (US9464073, 001 | US9884850, Compound 1) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.90 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Acetylon Pharmaceuticals, Inc. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... | US Patent US9464073 (2016) BindingDB Entry DOI: 10.7270/Q2TD9W8Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 6 (Homo sapiens (Human)) | BDBM249366 (US9464073, 003 | US9884850, Compound 3) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid PDB UniChem | US Patent | n/a | n/a | 3.70 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Acetylon Pharmaceuticals, Inc. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... | US Patent US9464073 (2016) BindingDB Entry DOI: 10.7270/Q2TD9W8Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 6 (Homo sapiens (Human)) | BDBM249367 (US9464073, 004 | US9884850, Compound 4) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.90 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Acetylon Pharmaceuticals, Inc. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... | US Patent US9464073 (2016) BindingDB Entry DOI: 10.7270/Q2TD9W8Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 2 (Homo sapiens (Human)) | BDBM249365 (US9464073, 002 | US9884850, Compound 2) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 108 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Acetylon Pharmaceuticals, Inc. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... | US Patent US9464073 (2016) BindingDB Entry DOI: 10.7270/Q2TD9W8Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM249365 (US9464073, 002 | US9884850, Compound 2) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 117 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Acetylon Pharmaceuticals, Inc. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... | US Patent US9464073 (2016) BindingDB Entry DOI: 10.7270/Q2TD9W8Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 3 (Homo sapiens (Human)) | BDBM249365 (US9464073, 002 | US9884850, Compound 2) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 671 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Acetylon Pharmaceuticals, Inc. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... | US Patent US9464073 (2016) BindingDB Entry DOI: 10.7270/Q2TD9W8Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM249367 (US9464073, 004 | US9884850, Compound 4) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 703 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Acetylon Pharmaceuticals, Inc. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... | US Patent US9464073 (2016) BindingDB Entry DOI: 10.7270/Q2TD9W8Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 2 (Homo sapiens (Human)) | BDBM249367 (US9464073, 004 | US9884850, Compound 4) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 833 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Acetylon Pharmaceuticals, Inc. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... | US Patent US9464073 (2016) BindingDB Entry DOI: 10.7270/Q2TD9W8Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 2 (Homo sapiens (Human)) | BDBM249364 (US9464073, 001 | US9884850, Compound 1) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 870 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Acetylon Pharmaceuticals, Inc. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... | US Patent US9464073 (2016) BindingDB Entry DOI: 10.7270/Q2TD9W8Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM249366 (US9464073, 003 | US9884850, Compound 3) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid PDB UniChem | US Patent | n/a | n/a | 961 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Acetylon Pharmaceuticals, Inc. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... | US Patent US9464073 (2016) BindingDB Entry DOI: 10.7270/Q2TD9W8Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 2 (Homo sapiens (Human)) | BDBM249366 (US9464073, 003 | US9884850, Compound 3) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid PDB UniChem | US Patent | n/a | n/a | 982 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Acetylon Pharmaceuticals, Inc. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... | US Patent US9464073 (2016) BindingDB Entry DOI: 10.7270/Q2TD9W8Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM249364 (US9464073, 001 | US9884850, Compound 1) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.04E+3 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Acetylon Pharmaceuticals, Inc. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... | US Patent US9464073 (2016) BindingDB Entry DOI: 10.7270/Q2TD9W8Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 3 (Homo sapiens (Human)) | BDBM249367 (US9464073, 004 | US9884850, Compound 4) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.82E+3 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Acetylon Pharmaceuticals, Inc. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... | US Patent US9464073 (2016) BindingDB Entry DOI: 10.7270/Q2TD9W8Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 3 (Homo sapiens (Human)) | BDBM249366 (US9464073, 003 | US9884850, Compound 3) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid PDB UniChem | US Patent | n/a | n/a | 4.38E+3 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Acetylon Pharmaceuticals, Inc. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... | US Patent US9464073 (2016) BindingDB Entry DOI: 10.7270/Q2TD9W8Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 3 (Homo sapiens (Human)) | BDBM249364 (US9464073, 001 | US9884850, Compound 1) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.20E+3 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Acetylon Pharmaceuticals, Inc. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... | US Patent US9464073 (2016) BindingDB Entry DOI: 10.7270/Q2TD9W8Z | |||||||||||
More data for this Ligand-Target Pair |